# Karyopharm Therapeutics Inc.: filings

KPTI · Nasdaq · CIK 1503802 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kpti.md) · [Financials](/companies/kpti/financials.md) · [Filings](/companies/kpti/filings.md) · [Insiders](/companies/kpti/insiders.md)

## Reports and events: 270 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 560, 8-K 193, SC 13G/A 63, 10-Q 39, 3 36, SC 13G 25, S-8 21, SCHEDULE 13G/A 18, 424B5 15, CORRESP 15, DEF 14A 15, DEFA14A 14, 10-K 13, EFFECT 11, SCHEDULE 13G 11, UPLOAD 11, S-3 9, CT ORDER 7, ARS 5, PRE 14A 5, 5 4, D 4, S-3ASR 4, POS AM 3, S-1 3, 10-Q/A 2, 424B3 2, 424B4 2, POSASR 2, S-1/A 2, S-1MEF 2, SC 13D/A 2, 144 1, 4/A 1, 8-A12B 1, CERTNAS 1, DRS 1, DRSLTR 1, RW 1, S-3/A 1, SC 13D 1, SC TO-C 1, SC TO-I 1, SC TO-I/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 16:15 ET | [8-K](/filings/0001193125-26-428938.md) | 8.01 Other events | 0001193125-26-428938 |
| 2026-10-14 | 07:30 ET | [8-K](/filings/0001193125-26-421025.md) | 8.01 Other events | 0001193125-26-421025 |
| 2026-09-18 | 16:05 ET | [8-K](/filings/0001193125-26-395517.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-395517 |
| 2026-09-11 | 07:45 ET | [8-K](/filings/0001193125-26-388621.md) | 1.01 Entry into a material agreement; 2.04 Item not in the standard list; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-388621 |
| 2026-08-31 | 08:08 ET | [8-K](/filings/0001193125-26-375495.md) | 8.01 Other events | 0001193125-26-375495 |
| 2026-08-13 | 07:40 ET | [10-Q](/filings/0001193125-26-347906.md) | Quarterly report, period 2026-06-30 | 0001193125-26-347906 |
| 2026-08-13 | 07:37 ET | [8-K](/filings/0001193125-26-347897.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-347897 |
| 2026-07-31 | 08:30 ET | [8-K](/filings/0001193125-26-326995.md) | 8.01 Other events | 0001193125-26-326995 |
| 2026-07-17 | 17:01 ET | [8-K](/filings/0001193125-26-307964.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-307964 |
| 2026-05-28 | 16:15 ET | [8-K](/filings/0001503802-26-000027.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001503802-26-000027 |
| 2026-05-14 | 07:45 ET | [10-Q](/filings/0001193125-26-222827.md) | Quarterly report, period 2026-03-31 | 0001193125-26-222827 |
| 2026-05-14 | 07:32 ET | [8-K](/filings/0001193125-26-222808.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-222808 |
| 2026-04-13 | 08:23 ET | [DEF 14A](/filings/0001503802-26-000023.md) | Proxy statement, period 2026-04-13 | 0001503802-26-000023 |
| 2026-03-27 | 08:04 ET | [8-K](/filings/0001503802-26-000011.md) | 8.01 Other events | 0001503802-26-000011 |
| 2026-03-24 | 08:00 ET | [8-K](/filings/0001193125-26-120770.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-120770 |
| 2026-03-03 | 17:57 ET | [8-K](/filings/0001503802-26-000006.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001503802-26-000006 |
| 2026-02-19 | 16:06 ET | [8-K](/filings/0001193125-26-059349.md) | 5.07 Shareholder vote results | 0001193125-26-059349 |
| 2026-02-13 | 20:38 ET | [10-K](/filings/0001193125-26-049397.md) | Annual report, period 2025-12-31 | 0001193125-26-049397 |
| 2026-02-12 | 07:32 ET | [8-K](/filings/0001193125-26-047670.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-047670 |
| 2026-01-12 | 07:04 ET | [8-K](/filings/0001193125-26-009738.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-009738 |
| 2026-01-09 | 16:15 ET | [DEF 14A](/filings/0001193125-26-008939.md) | Proxy statement, period 2026-02-18 | 0001193125-26-008939 |
| 2025-11-03 | 07:14 ET | [10-Q](/filings/0001193125-25-261667.md) | Quarterly report, period 2025-09-30 | 0001193125-25-261667 |
| 2025-11-03 | 07:10 ET | [8-K](/filings/0001193125-25-261663.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-261663 |
| 2025-10-14 | 16:11 ET | [8-K](/filings/0001193125-25-239015.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-239015 |
| 2025-10-08 | 07:05 ET | [8-K](/filings/0001193125-25-233983.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-233983 |
| 2025-09-11 | 16:33 ET | [8-K](/filings/0001503802-25-000006.md) | 5.02 Departure or appointment of officers or directors | 0001503802-25-000006 |
| 2025-08-11 | 07:34 ET | [10-Q](/filings/0000950170-25-106238.md) | Quarterly report, period 2025-06-30 | 0000950170-25-106238 |
| 2025-08-11 | 07:31 ET | [8-K](/filings/0000950170-25-106236.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106236 |
| 2025-07-11 | 07:28 ET | [8-K](/filings/0000950170-25-095167.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-095167 |
| 2025-05-29 | 16:28 ET | [8-K](/filings/0000950170-25-079009.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-079009 |
| 2025-05-12 | 16:14 ET | [10-Q](/filings/0000950170-25-069231.md) | Quarterly report, period 2025-03-31 | 0000950170-25-069231 |
| 2025-05-12 | 16:06 ET | [8-K](/filings/0000950170-25-069176.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069176 |
| 2025-04-14 | 08:15 ET | [DEF 14A](/filings/0000950170-25-053511.md) | Proxy statement, period 2025-05-28 | 0000950170-25-053511 |
| 2025-02-24 | 16:16 ET | [8-K](/filings/0000950170-25-025640.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-025640 |
| 2025-02-19 | 07:36 ET | [10-K](/filings/0000950170-25-022765.md) | Annual report, period 2024-12-31 | 0000950170-25-022765 |
| 2025-02-19 | 07:32 ET | [8-K](/filings/0000950170-25-022764.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-022764 |
| 2025-01-31 | 16:05 ET | [8-K](/filings/0001193125-25-018385.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-018385 |
| 2025-01-30 | 16:06 ET | [8-K](/filings/0001193125-25-017223.md) | 5.07 Shareholder vote results | 0001193125-25-017223 |
| 2025-01-13 | 08:34 ET | [8-K](/filings/0000950170-25-004591.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-004591 |
| 2025-01-02 | 07:08 ET | [8-K](/filings/0000950170-25-000092.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-000092 |
| 2024-12-16 | 16:00 ET | [DEF 14A](/filings/0000950170-24-136598.md) | Proxy statement, period 2025-01-30 | 0000950170-24-136598 |
| 2024-12-03 | 07:09 ET | [8-K](/filings/0001193125-24-269398.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-269398 |
| 2024-11-20 | 16:11 ET | [8-K](/filings/0001193125-24-262541.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-262541 |
| 2024-11-08 | 16:05 ET | [8-K](/filings/0000950170-24-124067.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-124067 |
| 2024-11-05 | 07:47 ET | [10-Q](/filings/0000950170-24-121076.md) | Quarterly report, period 2024-09-30 | 0000950170-24-121076 |
| 2024-11-05 | 07:41 ET | [8-K](/filings/0001193125-24-250984.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-250984 |
| 2024-10-31 | 07:41 ET | [8-K](/filings/0001193125-24-248162.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-248162 |
| 2024-09-17 | 16:10 ET | [8-K](/filings/0001193125-24-220534.md) | 3.01 Delisting notice | 0001193125-24-220534 |
| 2024-08-29 | 16:05 ET | [8-K](/filings/0001193125-24-209907.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-209907 |
| 2024-08-06 | 07:42 ET | [10-Q](/filings/0000950170-24-091210.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091210 |

Page 1 of 6. [Older](/companies/kpti/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 04:32 ET. No prices; not investment advice.